NCT03832465View on ClinicalTrials.gov

Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

December 27, 2020

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Levofloxacin film-coated tablet

"50 participants are randomly assigned to receive intraluminal eradication of H. pylori.~with medicaments containing levofloxacin powder or levofloxacin solution."

DRUG

Levofloxacin intravenous solution

"50 participants are randomly assigned to receive intraluminal eradication of H. pylori.~with medicaments containing levofloxacin powder or levofloxacin solution."

Trial Locations (1)

10449

Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT03832465 - Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution | Biotech Hunter | Biotech Hunter